Literature DB >> 12700706

Immunoglobulins as an alternative strategy of psychopharmacological treatment of children with autistic disorder.

Helmut Niederhofer, W Staffen, A Mair.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700706     DOI: 10.1038/sj.npp.1300130

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  6 in total

Review 1.  Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families.

Authors:  R Scott Akins; Kathy Angkustsiri; Robin L Hansen
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 2.  Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications.

Authors:  Evdokia Anagnostou; Robin Hansen
Journal:  Curr Opin Pediatr       Date:  2011-12       Impact factor: 2.856

3.  What is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature?

Authors:  Graham E Ewing
Journal:  N Am J Med Sci       Date:  2009-07

4.  Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism.

Authors:  Kathleen Connery; Marie Tippett; Leanna M Delhey; Shannon Rose; John C Slattery; Stephen G Kahler; Juergen Hahn; Uwe Kruger; Madeleine W Cunningham; Craig Shimasaki; Richard E Frye
Journal:  Transl Psychiatry       Date:  2018-08-10       Impact factor: 6.222

Review 5.  A Systematic Review and Meta-Analysis of Immunoglobulin G Abnormalities and the Therapeutic Use of Intravenous Immunoglobulins (IVIG) in Autism Spectrum Disorder.

Authors:  Daniel A Rossignol; Richard E Frye
Journal:  J Pers Med       Date:  2021-05-30

Review 6.  Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.

Authors:  Richard E Frye; Daniel A Rossignol
Journal:  Clin Med Insights Pediatr       Date:  2016-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.